Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs 7,238
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Pipeline programs

Page 21 of 151

  1. Armodafinil 150 mg/day

    Teva Pharma GmbH

    Fatigue

    phase 2 small molecule terminated

    1 trial

  2. Arsenic Trioxide

    Teva Pharma GmbH

    Lung Cancer

    phase 2 small molecule completed

    1 trial

  3. Art-BTC

    Hospital Authority, Hong Kong

    Biliary Cancer Metastatic

    phase 2 small molecule active

    1 trial

  4. Arvisol placebo, Arvisol 150mg

    Pari Pharma GmbH

    Patients with severe Alcohol Use Disorder (according to DSM 5) at entry of a scheduled inpatient alcohol cessation attempt

    phase 2 small molecule active

    1 trial

  5. Asciminib, ASCIMINIB HYDROCHLORIDE

    Novartis Pharmaceuticals

    Philadelphia positive Chronic Myeloid leukemia in Chronic Phase with newly diagnosed and resistant/intolerant to previous TKIs, with or without the T315I mutation

    phase 2 small molecule active

    1 trial

  6. AskBio009

    Takeda

    Hemophilia B

    phase 2 mab active

    1 trial

  7. Asparaginase Erwinia chrysanthemi

    Jazz Pharmaceuticals Ireland Limited

    B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

    phase 2 small molecule active

    1 trial

  8. Aspirin

    Cardiff Oncology

    Venous Leg Ulcer

    phase 2 small molecule terminated

    1 trial

  9. Aspirin

    United Therapeutics Europe Ltd

    Vestibular Schwannoma

    phase 2 small molecule active

    1 trial

  10. Aspirin 75mg

    United Therapeutics Europe Ltd

    Acute Lung Injury

    phase 2 small molecule completed

    1 trial

  11. Aspirin Challenge

    Regeneron UK Limited

    Aspirin-exacerbated Respiratory Disease

    phase 2 small molecule completed

    1 trial

  12. Assets Getting To Outcomes

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 2 other completed

    1 trial

  13. Association atezolizumab + BDB001 + RT

    Eikon Therapeutics

    Solid Tumor, Adult

    phase 2 small molecule active

    1 trial

  14. Atacicept

    Vera Therapeutics

    IgA Nephropathy (IgAN); Berger Disease; Renal and Urinary Disorders

    phase 2 small molecule active

    1 trial

  15. Atacicept

    Vera Therapeutics

    pMN

    phase 2 small molecule active

    1 trial

  16. Atacicept

    Vera Therapeutics

    IgA Nephropathy (IgAN)

    phase 2 small molecule active

    1 trial

  17. Atacicept 150 mg

    Vera Therapeutics

    IgA Nephropathy (IgAN)

    phase 2 small molecule active

    1 trial

  18. Atacicept 75 mg

    Serono Europe Limited

    Lupus Erythematosus, Systemic

    phase 2 small molecule terminated

    1 trial

  19. Atacicept Autoinjector Combination, Atacicept

    Vera Therapeutics

    Multiple Autoimmune Glomerular Diseases

    phase 2 small molecule active

    1 trial

  20. Atacicept Autoinjector Combination, Atacicept

    Vera Therapeutics

    Treatment of IgAN

    phase 2 small molecule active

    1 trial

  21. Ataluren

    PTC THERAPEUTICS, INC.

    Nonsene Mutation Duchenne Muscular Dystrophy

    phase 2 small molecule completed

    1 trial

  22. Ataluren

    PTC THERAPEUTICS, INC.

    Amino Acid Metabolism, Inborn Errors

    phase 2 small molecule terminated

    1 trial

  23. Ataluren

    PTC THERAPEUTICS, INC.

    Hemophilia A

    phase 2 small molecule terminated

    1 trial

  24. Ataluren

    PTC THERAPEUTICS, INC.

    Aniridia

    phase 2 small molecule terminated

    2 trials

  25. Ataluren + Pembrolizumab

    PTC THERAPEUTICS, INC.

    Colorectal Cancer

    phase 2 small molecule active

    1 trial

  26. Atezolizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Small-cell Lung Cancer

    phase 2 small molecule active

    1 trial

  27. Atezolizumab

    United Therapeutics Europe Ltd

    Metastatic Colorectal Carcinoma

    phase 2 small molecule completed

    1 trial

  28. Atezolizumab

    United Therapeutics Europe Ltd

    Locally Advanced Hepatocellular Carcinoma

    phase 2 mab active

    1 trial

  29. Atezolizumab

    HALOZYME THERAPEUTICS, INC.

    Pancreatic Ductal Adenocarcinoma

    phase 2 small molecule terminated

    1 trial

  30. Atezolizumab

    BEONE MEDICINES AUS PTY LTD

    Advanced Liver Cancers

    phase 2 small molecule active

    1 trial

  31. Atezolizumab

    The University of Hong Kong

    NSCLC Stage IIIB

    phase 2 small molecule active

    1 trial

  32. Atezolizumab

    Arcus Biosciences

    Prostate Adenocarcinoma

    phase 2 small molecule active

    1 trial

  33. Atezolizumab

    Oncotelic Therapeutics

    Metastatic Lung Non-Small Cell Carcinoma

    phase 2 mab terminated

    1 trial

  34. Atezolizumab

    Syndax Pharmaceuticals

    Metastatic Cancer

    phase 2 small molecule terminated

    1 trial

  35. Atezolizumab

    Hoffmann-La Roche

    Advanced Liver Cancers

    phase 2 small molecule active

    1 trial

  36. Atomoxetin STADA 40 mg Hartkapseln, GELATIN

    Pari Pharma GmbH

    Healthy subjects with no neurological or psychiatric disorders

    phase 2 small molecule active

    1 trial

  37. Atomoxetine

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Dependence

    phase 2 small molecule completed

    1 trial

  38. Atomoxetine

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Abuse

    phase 2 small molecule completed

    1 trial

  39. Atomoxetine

    BRIGHT MINDS BIOSCIENCES INC.

    Attention Deficit Disorder With Hyperactivity

    phase 2 small molecule completed

    1 trial

  40. Atorvastatin

    Hospital Authority, Hong Kong

    Vitiligo

    phase 2 small molecule completed

    1 trial

  41. Atorvastatin

    The First People's Hospital of Lianyungang

    Myocardial Infarction

    phase 2 small molecule active

    1 trial

  42. Atorvastatin Calcium

    United Therapeutics Europe Ltd

    Traumatic Brain Injury

    phase 2 small molecule active

    1 trial

  43. Atorvastatin Oral Tablet

    Chongqing Precision Biotech Co., Ltd

    Mild Cognitive Impairment

    phase 2 small molecule active

    1 trial

  44. Atorvastatin injection

    CUMBERLAND PHARMACEUTICALS INC

    Hypercholesterolemia

    phase 2 small molecule completed

    1 trial

  45. Atu027 & gemcitabine in lead in safety period

    Silence Therapeutics plc

    Carcinoma, Pancreatic Ductal

    phase 2 small molecule completed

    1 trial

  46. Atuliflapon

    AstraZeneca

    Asthma

    phase 2 small molecule completed

    1 trial

  47. Aumolertinib

    The First People's Hospital of Lianyungang

    Lung Cancer

    phase 2 small molecule active

    1 trial

  48. Aumolertinib Oral Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer Stage IV

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.